Filing metadata

Accession number
0001493152-22-016081
Form type
Form 4
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Jun 07, 2022
Reporting period
Jun 01, 2022
Description
Insider transaction

Explore SEC Filings Hub